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Abstract: 1-Methyl-y-carboline derivatives were transformed into the corresponding N-aminoazinium salts, which 
were condensed with 1,2-dicarbonyl compounds (Westphal reaction) to afford azonia derivatives with a bridgehead 
quaternary nitrogen atom. Some of them show DNA intercalating properties. Copyright © 1996 Elsevier Science Ltd 
Since DNA is an important cellular receptor, most anticancer agents exert their effects trough binding to it. 
Intercalation is one of these modes of interaction, in which a molecule is inserted between two adjacent base pairs 
causing lengthening, stiffening and unwinding of the helix. ~ Planar polyheteroaromatic cations are particularly well 
adapted for intercalation between nucleic acid base pairs. While the positive charge in the chromophore seems to 
be essential for increasing their DNA affinity, 2 their orientation in the intercalative proccess is highly dependent on 
the electrostatic component of the stacking interaction. Favourable dipolar interactions between the chromophore 
.and the base pairs contribute to explain the observed selectivity for CpG or TpA steps. 3 For these reasons, 
alterations of the dipole moment of the chromophore is an important element to be considered when DNA bis- 
intercalators are being designed. 
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The above considerations led us to explore the DNA binding properties of type 1 azonia derivatives, 
incorporating as chromophore a polyheteroaromatic cation, in which the positive charge is not introduced by N- 
alkylation of the azaheterocycle, such is the case of well known DNA intercalators, such as ethidium bromide and 
some antitumour compounds of the ellipticine group (e. g. Crliptium®),. but by the presence of a quaternary 
bridgehead nitrogen. 4 In this communication we wish to report our initial results on the transformation of the "y- 
carboline system into tetracyclic and beptacyclic azonia derivatives, along with the DNA binding properties and 
charge distribution of a representative compound. 
The 1-methylcarbolines were prepared by thermal or microwave decomposition of the corresponding 
pyridylbenzotriazoles 2 (Graebe-Ullmann reaction) 5 as previously described. 6 These derivatives were easily 
transformed into the salts 3 by amination with (O-mesitylenesulfonyl)hydroxylamine (MSH) in CH2C12 at room 
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temperature. The reaction of 3 with various 1,2-dicarbonyl compounds (Westphal condensation) 7 afforded several 
types of azonia derivatives (Scheme 1). Different reaction conditions were necessary for the condensation to be 
successful. Thus, to obtain the polyeyclic cations 5 and 6 from the reaction of 3 with 1,2-acenaphthoqninone and 
9,10-phenanthrenequinone, the condensation had to be carried out in sodium acetate/acetone whereas in the reaction 
of 3 with 2,3-butanedione or 3,4-hexanedione, 4a-d could only be obtained if triethylamine//vleOH/acetone was 
employed. The derivative 4e required the use of dibutylamine/EtOH. 
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4b: R 1 = Me; R 2 = R 3 = H; R 4 = Me (63%) 
4©: R 1 = R 2 = R 3 = H; R 4 = Et (82%) 
4d: R 1 = Me; R 2 = R 3 = H; R 4 = Et (76%) 
R ,N  _ 411: R 1 = R 2 =R 3 = Me; R 4 = El (72%1 
X = Meeityleneeulphonate 
H 
6©: R 1 = R 2 = R 3 = H (81%) 
6b: R 1 = R 2 = R 3 = Me (83%) 
1. i) 150-200° C or MW, 160 watts; ii) MSH/CH2CI2 ;  iii) R4COCOR 4, Et3N/EtOH-acetone or 
Bu2NH / EtOH; iv) 1,2-Aclnsphthoquinone, NaOAc I acetone; v) 9,10-Phenanthrenequinone, NaOAc / acetone 
Several techniques s were used to evaluate the DNA binding properties of azonia derivatives 4-6. Whereas the 
addition of compounds 5 and 6 to a sample of calf thymus DNA in TRIS-HC1 buffer ([NaC1]=0.05 M, pH=7.5) 
induced hyperchromicity, probably due to dipole-dipole interactions, the cationic derivatives 4 gave hypochromic 
and bathochromic shifts in their Lrv spectra (see Table) accounted for by their binding to DNA. 9 The unique binding 
mode with DNA was established by the appearance of isosbestic points for this series of compounds. From the 
spectral changes, nonlinear Scatchard binding isotherms were generated. The McGhee-Von Hippe 11° treatment 
allowed the values of K (DNA affinity constant) and n (number of base-pairs occluded by each bound ligand 
molecule) to he determined. Intercalation was proved by measuring the viscosity of sonicated calf thymus DNA in 
the absence and presetw, e of increasing concentrations of 4. The slope n (m) obtained by plotting the relative increase 
in contour length (/./Lo) against the ligand binding ratio (r) gave values within the range of well known intercalators 
such as ethidium bromide, ~2 used here as reference. In the Table are shown the values for each compound m3 along 
with their cellular toxicity against colon carcinoma HT-29 cells. ~4 Although the number of analised compounds is 
small, the presence and position of alkyl groups appears to have only a small effect on K values. ECso values indicate 
that inhibitory activity is enhanced by alkyl substitution, with the tetrasubstituted derivative 4e being the most potent 
of this series whilst the monosubstituted derivatives 4a and 4c were significantly less potent. 
To be used in the comparison with other DNA intercalators, the optimized geometries and atomic charges of 
the cation 4a and the betaine 7 were determined using ab initio theoretical techniques ~5 (HF/6-31G*//HF/3-21G) 
and are presented in Figure 2. Calculations show that both are planar structures, determined as minima by frequency 
calculations. As a result, the easily formed and highly stable compound 7 seems better represented by the resonance 
hybrid 7-8 (Scheme 2). 
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Figure 3 
Table. DNA Bindin s Properties of Azonia Derivatives 4 
Compd. No ~.t~ ~.~,,t et~ e~,~ ~.ir 10 5 K n m ECso [~M] 
4a 354 364 7637 4845 388 1.10 4.75 1.16 >10 
4b 358 368 7187 4461 388 2.39 2.84 0.97 2.0 
4c 352 362 7451 5056 390 1.27 3.98 0.95 >10 
4(! 356 366 7036 4651 388 2.62 3.56 0.87 2.1 
41e 368 384 5887 3547 398 1.45 3.00 0.77 0.5 
EtBr . . . . . . . . . .  12.0 ZOO= 1.11 -- 
K: affinity constant for DNA (M-l). n: Numbe: of base-pairs occluded by each bound ligand molecule, m: Helix extension slope 
measured by sonicated DNA viscosimettic lengthening; values within 0.09-0.13 error. ~.~ and ~.b=m: Wavelength of maximum 
absorption for free and DNA bound compounds, ee,. and eb,=d: Extinction coefficients for free and DNA bound compounds. 
ka~ Wavelength of isosbeatic point. ECso: Concentration of drug required to inhibit 50% of the cell growth after 72 h, of colon 
carcinoma HT-29. In vitro activity was measured as indicated in ref. 14 (doxorubicin, EC50=2.5). EtBr: Ethidiurn bromide. 
• Value according to neighbor exclusion model (ref. 16) 
In summary, this work presents a series of new pyridazino[ 1 ",6": 1,2]pyrido[4,3-b]indol-5-inium salts which 
shown both batho- and hypochromicity in their UV spectra in the presence of DNA and increased viscosity in 
sonicated DNA. Transformation into bis-salts is now under way in order to improve on the observed affimty 
constants in these new DNA intercalators. 
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